Cross-cultural adaptation,reliability and validity testing of the Chinese version of Brain Metastases Symptom Checklist

doi:10.3969/j.issn.1674-8115.2021.12.005

Abstract

Abstract: Objective

·To translate the English version of Brain Metastases Symptom Checklist (BMSC) into Chinese version and test its reliability and validity.

Methods

·The translation and adaption of BMSC for the Chinese population were generated by Brislin translation and back-translation model. From January 2017 to June 2019, a sample of 239 brain metastases patients matched with the inclusion criteria were selected via convenience sampling from the Center for Functional Neurosurgery, Department of Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine and Gamma Knife Center, Shandong Provincial Hospital affiliated to Shandong First Medical University. The Cronbach's α coefficient was used to evaluate the internal consistency, and the intra-class correlation coefficient (ICC) was used to determine the retest reliability. The item-related content validity index (ICV) and the scale-level average content validity index (S-CVI/Ave) were applied to assess the content validity of the Chinese version of BMSC. The effective size (ES) was calculated to evaluate the responsiveness of the Chinese version of BMSC, and the minimal clinical important difference (MCID) of the Chinese version of BMSC was evaluated by using anchor-based approach and distribution-based approach respectively.

Results

·The Cronbach's α coefficient of the Chinese version of BMSC was 0.85, and the ICC reflecting retest reliability was 0.72. The I-CVI was 0.8?1.0, and the S-CVI/Ave was 0.97. The scores of the Chinese version of BMSC before and after gamma knife treatment showed significant differences (P<0.05), and the ES of the Chinese version of BMSC was 0.01?0.35. The MCID value of BMSC score obtained by anchor-based method was 0.07?1.28, and the value obtained by distribution-based method was 0.01?0.60.

Conclusion

·The Chinese version of BMSC has good validity and reliability.

Key words: brain metastases, symptom, scale, reliability, validity

CLC Number:

R473.73

Xian QIU, Wei-yi ZHU, Peng ZHAO, Si-jian PAN, Bo-min SUN, Bei-wen WU. Cross-cultural adaptation,reliability and validity testing of the Chinese version of Brain Metastases Symptom Checklist[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(12): 1573-1578.

Figures/Tables 3

TrendMD

References 17

1	Kaal EC, Niël CG, Vecht CJ. Therapeutic management of brain metastasis[J]. Lancet Neurol, 2005, 4(5): 289-298.
2	赵东海, 杜汉强,王嘉嘉,等. 伽玛刀治疗对脑转移瘤病人认知功能及生活质量影响的研究[J]. 中国微侵袭神经外科杂志, 2020, 25(5): 205-208.
3	Bezjaka A. Adam J, Barton R.et al. Symptom response after palliative radiotherapy for patients with brain metastases[J]. Eur J Cancer, 2002, 38(4): 487-496.
4	Rodin D, Banihashemi B, Wang L, et al. The Brain Metastases Symptom Checklist as a novel tool for symptom measurement in patients with brain metastases undergoing whole-brain radiotherapy[J]. Curr Oncol, 2016, 23(3): e239-e247.
5	孙振球. 医学统计学[M]. 北京: 人民卫生出版社, 2010: 273.
6	Brislin RW. Back-translation for cross-cultural research[J]. J Cross Cult Psychol, 1970, 1(3): 185-216.
7	Hays RD, Hadorn D. Responsiveness to change: an aspect of validity, not a separate dimension[J]. Qual Life Res, 1992, 1(1): 73-75.
8	Revicki D, Hays RD, Cella D, et al. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes[J]. J clin Epidemiol, 2008, 61(2): 102-109.
9	Davis LL. Instrument review: getting the most from a panel of experts[J]. App Nurs Res, 1992, 5:194-197.
10	张方圆, 沈傲梅, 马婷婷,等. 中国癌症症状管理实践指南计划书[J]. 护理研究, 2018, 32(1): 8-12.
11	唐华, 王甦平, 龚睿婕, 等. 挫败感量表对医学生焦虑抑郁态的信效度评估[J]. 上海交通大学学报(医学版), 2019, 39(1): 84-88.
12	Teke F, Bucaktepe P, Kıbrıslı E, et al. Quality of life, psychological burden, and sleep quality in patients with brain metastasis undergoing whole brain radiation therapy[J]. Clin J Oncol Nurs, 2016, 20(5): AE-A2.
13	Good P, Pinkerton R, Bowler S, et al. Impact of opioid therapy on sleep and respiratory patterns in adults with advanced cancer receiving palliative care[J]. J pain Symptom Manage, 2018, 55(3): 962-967.
14	Davidson JR, MacLean AW, Brundage MD, et al. Sleep disturbance in cancer patients[J]. Soc Sci Med, 2002, 54(9): 1309-1321.
15	Willis KD, Ravyts SG, Lanoye A, et al. Sleep disturbance in primary brain tumor: prevalence, risk factors, and patient preferences[J]. Support Care Cancer, 2021. DOI: 10.1007/s00520-021-06476-3.
16	戴海崎, 张锋, 陈雪枫. 心理与教育测量[M]. 广州: 暨南大学出版社, 2008: 59-65.
17	刘砚燕. 患者报告结局测量信息系统:儿童报告版和父母报告版癌症相关简表的测量学研究[D]. 上海: 第二军医大学, 2016.

Item	BMSC score/score			t value	P value	Responsiveness
Item	Before treatment	After treatment	Difference	t value	P value	ES	SRM
1	1.61±2.44	0.82±1.65	-0.77±2.47	0.30	0.00	0.31	0.31
2	2.21±3.00	1.73±2.58	-0.36±2.15	0.71	0.00	0.12	0.17
3	2.69±3.18	2.22±2.93	-0.43±2.80	0.57	0.00	0.13	0.15
4	1.91±2.86	1.57±2.59	-0.27±2.45	0.57	0.00	0.09	0.11
5	1.77±2.48	1.56±2.38	-0.50±2.15	0.63	0.00	0.20	0.23
6	1.17±2.24	0.82±1.89	-0.34±1.94	0.58	0.00	0.13	0.14
7	0.63±1.71	0.39±1.52	-0.11±1.24	0.67	0.00	0.06	0.09
8	2.18±2.50	2.22±2.52	-0.10±1.63	0.79	0.00	0.04	0.06
9	1.72±2.58	1.56±2.44	-0.07±2.11	0.64	0.00	0.02	0.03
10	0.95±1.91	0.54±1.61	-0.40±1.92	0.41	0.00	0.21	0.21
11	0.82±1.88	0.38±1.29	-0.37±1.60	0.51	0.00	0.19	0.23
12	1.70±2.35	1.05±1.87	0.82±2.06	0.57	0.00	0.35	0.40
13	1.82±2.47	1.63±2.31	-0.05±1.99	0.63	0.00	0.02	0.02
14	0.26±0.95	0.32±1.28	0.08±1.09	0.55	0.00	0.08	0.07
15	0.46±1.25	0.43±1.11	-0.02±1.21	0.46	0.00	0.02	0.02
16	2.43±2.81	1.99±2.69	-0.66±2.76	0.53	0.00	0.23	0.24
17	3.71±2.66	3.81±2.73	-0.03±2.51	0.54	0.00	0.01	0.01
18	1.23±2.25	0.83±1.66	-0.11±2.16	0.32	0.00	0.05	0.05

Item	BMSC score/score			t value	P value	Responsiveness
Item	Before treatment	After treatment	Difference	t value	P value	ES	SRM
1	1.61±2.44	0.82±1.65	-0.77±2.47	0.30	0.00	0.31	0.31
2	2.21±3.00	1.73±2.58	-0.36±2.15	0.71	0.00	0.12	0.17
3	2.69±3.18	2.22±2.93	-0.43±2.80	0.57	0.00	0.13	0.15
4	1.91±2.86	1.57±2.59	-0.27±2.45	0.57	0.00	0.09	0.11
5	1.77±2.48	1.56±2.38	-0.50±2.15	0.63	0.00	0.20	0.23
6	1.17±2.24	0.82±1.89	-0.34±1.94	0.58	0.00	0.13	0.14
7	0.63±1.71	0.39±1.52	-0.11±1.24	0.67	0.00	0.06	0.09
8	2.18±2.50	2.22±2.52	-0.10±1.63	0.79	0.00	0.04	0.06
9	1.72±2.58	1.56±2.44	-0.07±2.11	0.64	0.00	0.02	0.03
10	0.95±1.91	0.54±1.61	-0.40±1.92	0.41	0.00	0.21	0.21
11	0.82±1.88	0.38±1.29	-0.37±1.60	0.51	0.00	0.19	0.23
12	1.70±2.35	1.05±1.87	0.82±2.06	0.57	0.00	0.35	0.40
13	1.82±2.47	1.63±2.31	-0.05±1.99	0.63	0.00	0.02	0.02
14	0.26±0.95	0.32±1.28	0.08±1.09	0.55	0.00	0.08	0.07
15	0.46±1.25	0.43±1.11	-0.02±1.21	0.46	0.00	0.02	0.02
16	2.43±2.81	1.99±2.69	-0.66±2.76	0.53	0.00	0.23	0.24
17	3.71±2.66	3.81±2.73	-0.03±2.51	0.54	0.00	0.01	0.01
18	1.23±2.25	0.83±1.66	-0.11±2.16	0.32	0.00	0.05	0.05

Item	Anchor-based approach	Distribution-based approach
1	1.13±3.03	0.51
2	1.07±3.18	0.27
3	0.44±3.21	0.36
4	0.39±3.63	0.18
5	0.52±2.80	0.36
6	0.71±2.54	0.15
7	0 （0， 0）	0.04
8	0 （0， 0）	0.08
9	0.23±2.63	0.04
10	0.21±2.38	0.20
11	0.60±1.89	0.16
12	1.28±2.72	0.60
13	0.26±2.61	0.04
14	0 （0， 0）	0.02
15	0 （0， 0）	0.01
16	0.71±2.50	0.57
17	0.07±3.38	0.05
18	0.18±2.62	0.06

Item	Anchor-based approach	Distribution-based approach
1	1.13±3.03	0.51
2	1.07±3.18	0.27
3	0.44±3.21	0.36
4	0.39±3.63	0.18
5	0.52±2.80	0.36
6	0.71±2.54	0.15
7	0 （0， 0）	0.04
8	0 （0， 0）	0.08
9	0.23±2.63	0.04
10	0.21±2.38	0.20
11	0.60±1.89	0.16
12	1.28±2.72	0.60
13	0.26±2.61	0.04
14	0 （0， 0）	0.02
15	0 （0， 0）	0.01
16	0.71±2.50	0.57
17	0.07±3.38	0.05
18	0.18±2.62	0.06

[1]	Yu-ying CAI, Yan LIU. Application of Quality-of-Life Assessment Scales and psychological assessment tools to people with dry eye disease [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(9): 1252-1255.
[2]	Wen-jing QIAN, Ya-qing ZHANG. Development and analysis of reliability and validity of Operating Room Nurses' Job Stressor Scale [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(8): 1081-1088.
[3]	Yi WANG, Cheng CHENG, Hong-yan SHEN, Hong-yan GAO, Yue-ning DAI, Zheng-hui YI. Meta-analysis of efficacy of transcranial magnetic stimulation for the treatment of cognitive function and behavioral and psychological symptoms of dementia in patients with Alzheimer′s disease [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(7): 931-941.
[4]	Ze-hui HUANG, Chun HU, Pu LI, Chun-li ZHANG, Jun-yan FANG, A-hui SONG, Shan WEI, Ou-yang JI, Yan TONG, Hai DENG, Ying-li LIU. Development of self-management scale for peritoneal dialysis at home and its reliability and validity analysis [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(7): 942-948.
[5]	Pu-yu LI, Jia-yue CHENG, Qiu-meng GU, Han-yang RUAN, Yong WANG, Qiang LIU, Yan-ru WU, Zhen WANG. Influence of obsessive beliefs and impulsivity traits on symptom dimensions of obsessive-compulsive disorder patients [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 756-760.
[6]	Shang-bin LIU, Hao YANG, Chen XU, Jing-wen DONG, Xiao-yue YU, Yong CAI, Dong YUAN, Ying WANG. Validity and reliability of the Chinese version of Defeat Scale in men who have sex with men [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 793-798.
[7]	Cheng LI, Ming-liang ZHANG, Ling-wen YING, Jiao-rong SU, Rui TAO, Xia YU, Yu-qian BAO, Jian ZHOU. Establishment of continuous glucose monitoring in mice and multiscale entropy analysis of glucose time series [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(2): 134-139.
[8]	Qun-feng WANG, Li CAO, Xing-hua LUAN. Review of clinical application of peripheral neuropathy scales [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(11): 1518-1523.
[9]	Lin-jie SHEN, Yu-xin HUANG, Yong WANG, Hua JIN. Review of non-invasive brain stimulation for the treatment of somatic symptoms in major depressive disorder [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(11): 1535-1539.
[10]	Da-ke SHI, Su-ping WANG, Rui-jie GONG, Yang NI, Yong CAI. Reliability and validity evaluation of Chinese version of Brief HIV Knowledge Questionnaire for HIV-negative sexually transmitted diseases patients [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(10): 1351-1358.
[11]	Jing TAO, Qing-zhi ZENG, Jin DANG, Jian-yin QIU. Reliability and Validity of Corona Virus Disease 2019 (COVID-19) Peritraumatic Distress Index (CPDI) [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(10): 1359-1365.
[12]	TANG Ye-zhou, SHI Yi-fan, HUANG Yu-xin, ZHAO Ya-juan, FU Hao, HUANG Jia, WANG Yong. Analysis on sleep quality and characteristics of depression patients with different degrees of anxiety [J]. , 2020, 40(3): 333-.
[13]	LIU Xiang, FANG Yuan, LI Xia. Clinical symptoms and mechanism of psychological and behavioral impairment pre-dementia [J]. , 2020, 40(2): 263-.
[14]	WEN Wan-jun1, CHEN Ye1, QIN Zong-hou1, LÜ Wang-qiang2, TANG Wei3, LU Wei-hong4, FAN Wei-xing2, ZHANG Chen4. Relationship between serum interleukin-6 level and depressive symptoms in schizophrenia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(12): 1618-1620.
[15]	WANG Su-ping1, 2, WANG Yi-chen2, 3, GONG Rui-jie1, 4#, GE Yun5, CAI Yong 1#. Validity and reliability of Acquired Capability for Suicide Scale in medical undergraduates [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(12): 1646-1651.